Key result
The Enhanced Self-Care HeartMapp mobile application resulted in zero hospital readmissions at 30 days compared to two readmissions in the control group among patients with congestive heart failure.
Why the study?
Patients with congestive heart failure often have limited ability to engage in self-management at home leading to increased hospitalizations, and novel digital technologies have been recommended to improve self-management.
Does an enhanced self-care mobile intervention (HeartMapp) reduce hospital readmission in patients with congestive heart failure?
RCT (n=18)
Open-label
Block randomization
No
Does an enhanced self-care mobile intervention (HeartMapp) reduce hospital readmission in patients with congestive heart failure?
A mobile technology-based enhanced self-care intervention demonstrated feasibility and potential efficacy in reducing 30-day hospital readmissions and improving self-care in patients with congestive heart failure.
Improved self-care in pilot RCT; leaves open efficacy and warrants larger trials before practice change.
Introduction: While people with congestive heart failure (CHF) are living longer, they often have limited ability to engage in treatment plans and self-management at home, thus resulting in increased hospitalizations. The use of novel digital technologies for improving self-management has been recommended for reducing CHF related hospitalizations. Objective: This pilot study compared a patient-centered enhanced self-care (ESC) intervention using a mobile system called “HeartMapp (HM)” (ESC HM) with an active wait listed control (WLC) group who received CHF education in reducing hospitalization rate and improving CHF outcomes. A total of 18 participants who met the inclusion criteria were block randomized to ESC HM (n=9) and active WLC group (n=9), both using similar mobile platform. Participants were followed for 30-days to examine the number of hospitalization and secondary outcomes including self-care, quality of life, and CHF knowledge. Results: Results showed that none of the participants randomized to ESC HM (n=9) were hospitalized during the study period of 30-days compared to two participants, both men (11%) in the WLC group. Additionally, clinically meaningful improvement in self-care management (t=3.38; p=0.006) and self-care confidence (6.7 vs 1.8; t=2.53; p=0.028) were observed in ESC HM group. Knowledge significantly improved in the ESC HM group while declined in the WLC group (t=2.37; p=0.037). Quality of life score declined by 2 points in the ESC HM group, while the WLC group score declined by 8 points (p=.08). Conclusion: Preliminary results of the pilot study demonstrated feasibility and potential efficacy of reducing hospitalization and improving CHF self-care; thus, warranting further evaluation in a well-designed large clinical trial.
No takes yet. Share an insight, caveat, or question.
Athilingam et al. (2021) conducted an RCT in Congestive heart failure (n=18). Enhanced Self-Care HeartMapp (ESC HM) mobile application vs. Active wait-listed control receiving CHF education via mobile phone was evaluated on Hospital readmissions at 30 days. The Enhanced Self-Care HeartMapp mobile application resulted in zero hospital readmissions at 30 days compared to two readmissions in the control group among patients with congestive heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: